The Intogen list of drivers did not include TP53 since there was only one mutation in the discovery set of tumours, but TP53 and three other genes (RB1, ATRX and ATM) were notably reported by Intogen as drivers in the pan-cancer analysis19. This evidence concerns the gene ATRX and cancer.